We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Robotic System Resurfaces Partial Knee Replacements

By HospiMedica International staff writers
Posted on 31 Dec 2012
A new system for performing unicondylar knee replacement (UKR) surgery provides surgeons with improved control when shaving bone tissue in preparation for implant placement.

The NavioPFS system consists of a three-dimensional (3D) camera, a visualization system, and a handheld resurfacing handpiece that provides real-time robotic precision freehand sculpting (PFS), similar to that of a computer-aided design/ computer-aided manufacturing (CAD/CAM) system. More...
The NavioPFS handpiece incorporates multiple intelligent control algorithms that allow the surgeon to precisely resurface bone, based on planning created using proprietary UKR surgical software that uses a computerized tomography (CT)-free approach with intraoperative planning.

The advanced algorithms provide real-time feedback detailing implant placement, kinematics, and range of motion, using information fed from a navigation system camera that continuously overlooks the surgery. When coupled with navigation tracking that reports the real-time relative positions of the handpiece and the patient, the system allows PFS and controlled, targeted bone removal, while at the same allowing the robotics to enforce a safety zone. The NavioPFS Robotic Resurfacing System is a product of Blue Belt Technologies (Pittsburgh, PA, USA), and has been approved by the US Food and Drug Administration (FDA).

“The entire Blue Belt team, including our physician advisors, has remained committed to providing orthopedic surgeons and hospitals a more precise and consistent technique to perform UKR procedures that takes into consideration the current economic environment in our healthcare system,” said Eric Timko, President and CEO of Blue Belt Technologies. “We are confident that NavioPFS accomplishes these goals, and provides excellent results for patients.”

UKR involves placing an implant on just one side of the knee, rather than over the entire surface of the knee joint, as in a total knee replacement (TKR). Because the incision is smaller than with a TKR, patients have less pain, spend less recovery time in the hospital, and can be active sooner. The procedure also reduces risks of infection or blood loss, and patients treated with UKR have more functionality and greater range of motion than patients treated with a TKR.

Related Links:

Blue Belt Technologies



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.